Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2004 Nov 4;64(5):659–663. doi: 10.1136/ard.2004.028753

Early referral recommendations for ankylosing spondylitis (including pre-radiographic and radiographic forms) in primary care

J Sieper 1, M Rudwaleit 1
PMCID: PMC1755504  PMID: 15528281

Full Text

The Full Text of this article is available as a PDF (83.6 KB).

Figure 1.

Figure 1

Open in a new tab

 Parameters suitable for screening and early referral of patients with low back pain with axial SpA by primary care physicians to a rheumatologist.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allali F., Breban M., Porcher R., Maillefert J. F., Dougados M., Roux C. Increase in bone mineral density of patients with spondyloarthropathy treated with anti-tumour necrosis factor alpha. Ann Rheum Dis. 2003 Apr;62(4):347–349. doi: 10.1136/ard.62.4.347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Amor B., Dougados M., Listrat V., Menkes C. J., Roux H., Benhamou C., Blotman F., Pattin S., Paolaggi J. B., Duquesnoy B. Are classification criteria for spondylarthropathy useful as diagnostic criteria? Rev Rhum Engl Ed. 1995 Jan;62(1):10–15. [PubMed] [Google Scholar]
  3. Amor B., Santos R. S., Nahal R., Listrat V., Dougados M. Predictive factors for the longterm outcome of spondyloarthropathies. J Rheumatol. 1994 Oct;21(10):1883–1887. [PubMed] [Google Scholar]
  4. Brandt J., Khariouzov A., Listing J., Haibel H., Sörensen H., Grassnickel L., Rudwaleit M., Sieper J., Braun J. Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis. Arthritis Rheum. 2003 Jun;48(6):1667–1675. doi: 10.1002/art.11017. [DOI] [PubMed] [Google Scholar]
  5. Braun J., Baraliakos X., Golder W., Brandt J., Rudwaleit M., Listing J., Bollow M., Sieper J., Van Der Heijde D. Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: evaluation of a new scoring system. Arthritis Rheum. 2003 Apr;48(4):1126–1136. doi: 10.1002/art.10883. [DOI] [PubMed] [Google Scholar]
  6. Braun J., Bollow M., Eggens U., König H., Distler A., Sieper J. Use of dynamic magnetic resonance imaging with fast imaging in the detection of early and advanced sacroiliitis in spondylarthropathy patients. Arthritis Rheum. 1994 Jul;37(7):1039–1045. doi: 10.1002/art.1780370709. [DOI] [PubMed] [Google Scholar]
  7. Braun J., Bollow M., Remlinger G., Eggens U., Rudwaleit M., Distler A., Sieper J. Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum. 1998 Jan;41(1):58–67. doi: 10.1002/1529-0131(199801)41:1<58::AID-ART8>3.0.CO;2-G. [DOI] [PubMed] [Google Scholar]
  8. Braun J., Brandt J., Listing J., Zink A., Alten R., Golder W., Gromnica-Ihle E., Kellner H., Krause A., Schneider M. Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet. 2002 Apr 6;359(9313):1187–1193. doi: 10.1016/s0140-6736(02)08215-6. [DOI] [PubMed] [Google Scholar]
  9. Calin A., Porta J., Fries J. F., Schurman D. J. Clinical history as a screening test for ankylosing spondylitis. JAMA. 1977 Jun 13;237(24):2613–2614. [PubMed] [Google Scholar]
  10. Davis John C., Jr, Van Der Heijde Désirée, Braun Jurgen, Dougados Maxime, Cush John, Clegg Daniel O., Kivitz Alan, Fleischmann Roy, Inman Robert, Tsuji Wayne. Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial. Arthritis Rheum. 2003 Nov;48(11):3230–3236. doi: 10.1002/art.11325. [DOI] [PubMed] [Google Scholar]
  11. Deyo R. A., Weinstein J. N. Low back pain. N Engl J Med. 2001 Feb 1;344(5):363–370. doi: 10.1056/NEJM200102013440508. [DOI] [PubMed] [Google Scholar]
  12. Dougados M., Béhier J. M., Jolchine I., Calin A., van der Heijde D., Olivieri I., Zeidler H., Herman H. Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis: a six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug. Arthritis Rheum. 2001 Jan;44(1):180–185. doi: 10.1002/1529-0131(200101)44:1<180::AID-ANR24>3.0.CO;2-K. [DOI] [PubMed] [Google Scholar]
  13. Dougados M., Dijkmans B., Khan M., Maksymowych W., van der Linden Sj, Brandt J. Conventional treatments for ankylosing spondylitis. Ann Rheum Dis. 2002 Dec;61 (Suppl 3):iii40–iii50. doi: 10.1136/ard.61.suppl_3.iii40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Dougados M., van der Linden S., Juhlin R., Huitfeldt B., Amor B., Calin A., Cats A., Dijkmans B., Olivieri I., Pasero G. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum. 1991 Oct;34(10):1218–1227. doi: 10.1002/art.1780341003. [DOI] [PubMed] [Google Scholar]
  15. Emery P., Breedveld F. C., Dougados M., Kalden J. R., Schiff M. H., Smolen J. S. Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide. Ann Rheum Dis. 2002 Apr;61(4):290–297. doi: 10.1136/ard.61.4.290. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Feldtkeller Ernst, Khan Muhammad Asim, van der Heijde Désirée, van der Linden Sjef, Braun Jürgen. Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int. 2002 Sep 3;23(2):61–66. doi: 10.1007/s00296-002-0237-4. [DOI] [PubMed] [Google Scholar]
  17. Gran J. T., Husby G., Hordvik M. Prevalence of ankylosing spondylitis in males and females in a young middle-aged population of Tromsø, northern Norway. Ann Rheum Dis. 1985 Jun;44(6):359–367. doi: 10.1136/ard.44.6.359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Gran J. T., Nordvåg B. Y. Referrals from general practice to an outpatient rheumatology clinic: disease spectrum and analysis of referral letters. Clin Rheumatol. 2000;19(6):450–454. doi: 10.1007/s100670070004. [DOI] [PubMed] [Google Scholar]
  19. Haibel H., Rudwaleit M., Braun J., Sieper J. Six months open label trial of leflunomide in active ankylosing spondylitis. Ann Rheum Dis. 2005 Jan;64(1):124–126. doi: 10.1136/ard.2003.019174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Jajić I. The role of HLA-B27 in the diagnosis of low back pain. Acta Orthop Scand. 1979 Aug;50(4):411–413. doi: 10.3109/17453677908989784. [DOI] [PubMed] [Google Scholar]
  21. Khan M. A., Khan M. K. Diagnostic value of HLA-B27 testing ankylosing spondylitis and Reiter's syndrome. Ann Intern Med. 1982 Jan;96(1):70–76. doi: 10.7326/0003-4819-96-1-70. [DOI] [PubMed] [Google Scholar]
  22. Mau W., Zeidler H., Mau R., Majewski A., Freyschmidt J., Stangel W., Deicher H. Clinical features and prognosis of patients with possible ankylosing spondylitis. Results of a 10-year followup. J Rheumatol. 1988 Jul;15(7):1109–1114. [PubMed] [Google Scholar]
  23. Mullighan C. G., Heatley S., Lester S., Rischmueller M., Gordon T. P., Bardy P. G. Fas gene promoter polymorphisms in primary Sjögren's syndrome. Ann Rheum Dis. 2004 Jan;63(1):98–101. doi: 10.1136/ard.2003.006056. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Rudwaleit M., Listing J., Brandt J., Braun J., Sieper J. Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor alpha blockers in ankylosing spondylitis. Ann Rheum Dis. 2004 Mar 22;63(6):665–670. doi: 10.1136/ard.2003.016386. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Rudwaleit M., van der Heijde D., Khan M. A., Braun J., Sieper J. How to diagnose axial spondyloarthritis early. Ann Rheum Dis. 2004 May;63(5):535–543. doi: 10.1136/ard.2003.011247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Sandström J., Andersson G. B., Rydberg L. HLA-B27 as a diagnostic screening tool in chronic low back pain. Scand J Rehabil Med. 1984;16(1):27–28. [PubMed] [Google Scholar]
  27. Underwood M. R., Dawes P. Inflammatory back pain in primary care. Br J Rheumatol. 1995 Nov;34(11):1074–1077. doi: 10.1093/rheumatology/34.11.1074. [DOI] [PubMed] [Google Scholar]
  28. Van Den Bosch Filip, Kruithof Elli, Baeten Dominique, Herssens Annemie, de Keyser Filip, Mielants Herman, Veys Eric M. Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy. Arthritis Rheum. 2002 Mar;46(3):755–765. doi: 10.1002/art.511. [DOI] [PubMed] [Google Scholar]
  29. van Tubergen A., Heuft-Dorenbosch L., Schulpen G., Landewé R., Wijers R., van der Heijde D., van Engelshoven J., van der Linden Sj. Radiographic assessment of sacroiliitis by radiologists and rheumatologists: does training improve quality? Ann Rheum Dis. 2003 Jun;62(6):519–525. doi: 10.1136/ard.62.6.519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. van der Linden S., Valkenburg H. A., Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984 Apr;27(4):361–368. doi: 10.1002/art.1780270401. [DOI] [PubMed] [Google Scholar]
  31. van der Linden S., Valkenburg H., Cats A. The risk of developing ankylosing spondylitis in HLA-B27 positive individuals: a family and population study. Br J Rheumatol. 1983 Nov;22(4 Suppl 2):18–19. doi: 10.1093/rheumatology/xxii.suppl_2.18. [DOI] [PubMed] [Google Scholar]
  32. van der Linden S., van der Heijde D. Ankylosing spondylitis. Clinical features. Rheum Dis Clin North Am. 1998 Nov;24(4):663-76, vii. doi: 10.1016/s0889-857x(05)70036-3. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES